Purpose of the Screening
- Identify hereditary risks for breast and ovarian cancers.
- Provide critical information for family members regarding genetic inheritance.
- Enable clinicians to develop intensive surveillance or preventive strategies.
The BRCA1 and BRCA2 genetic screening is a crucial proactive step to assess hereditary risks of breast and ovarian cancer, enabling personalized preventive plans to ensure your long-term health and safety.
Scientific name: BRCA1 and BRCA2 Genetic Screening
An advanced laboratory test analyzing DNA for mutations in BRCA1 and BRCA2 genes. It identifies hereditary cancer syndromes, allowing clinicians to develop precise monitoring and early prevention strategies for high-risk individuals.